NCT00236613View on ClinicalTrials.gov

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

385

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

July 31, 2001

Conditions
Obesity
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236613 - A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity | Biotech Hunter | Biotech Hunter